Palacios v. Boehringer Ingelheim Pharmaceuticals, Inc.

814 F. Supp. 2d 1357, 2011 WL 2837464
CourtDistrict Court, S.D. Florida
DecidedJuly 12, 2011
DocketCase No. X
StatusPublished
Cited by1 cases

This text of 814 F. Supp. 2d 1357 (Palacios v. Boehringer Ingelheim Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Palacios v. Boehringer Ingelheim Pharmaceuticals, Inc., 814 F. Supp. 2d 1357, 2011 WL 2837464 (S.D. Fla. 2011).

Opinion

ORDER ON MOTIONS FOR SUMMARY JUDGMENT

URSULA UNGARO, District Judge.

THIS CAUSE is before the Court upon Defendant Boehringer Ingelheim Pharmaceuticals, Inc.’s Motion for Summary Judgment (D.E. 103) and Plaintiff Graciela Palacios’s Motion for Partial Summary Judgment. (D.E. 109.) The Motions are ripe for disposition.

THE COURT has considered the Motions and pertinent portions of the record and is otherwise fully advised in the premises.

*1359 I. FACTUAL BACKGROUND

Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”) develops, manufactures and sells branded pharmaceutical products. (Castresana Affidavit, D.E. 104-1, Ex. A, ¶ 2.) All of the prescription medical products that Boehringer sells are available to consumers only via prescriptions written by a licensed healthcare provider. (Castresana Aff. ¶4.) Boehringer employs approximately 4,500 employees, approximately 2,300 of which are Pharmaceutical Sales Representatives (“PSRs”) (Castresana Aff. ¶ 5.) Plaintiff was employed by Boehringer as a PSR from July 7, 2003 to October 31, 2009. (Castresana Aff. ¶ 10.) 1

Plaintiffs position required her to work in a “Geo Team” with two other PSRs, each of whom was expected to visit physicians in South Florida. (Palacios Dep. at 73:11-16.) When she called on physicians, Plaintiff provided them with information about the benefits of particular Boehringer pharmaceuticals and encouraged them to prescribe those products. (Palacios Dep. at 104: 14-17.) However, Plaintiff did not sell any pharmaceuticals directly to physicians or patients. (Staak Deposition, D.E. 116-1, at 67:6-19, 76:20-22.) Rather, individuals in Boehringer’s Trade Relations and Managed Markets groups sold its pharmaceutical products to wholesale and retail customers. (Staak Dep. at 53-54; Conklin Deposition, D.E. 116-4, at 24:7-22, 26: 6-15.) No PSRs were employed in the Trade Relations or Managed Markets groups, and Plaintiff never worked in either of these groups. (Staak Dep. at 60:5-11; Conklin Dep. at 25:20-27:15; Palacios Declaration, D.E. 116-2, ¶ 15.)

Boehringer also maintained in its corporate headquarters separate departments for the functional areas of advertising, information technology, legal and regulatory compliance, sales operations, commercial operations, commercial analytics, managed markets, accounting/finance, safety and health, insurance, taxes, research and development, employee benefits, public relations, government relations, and human resources. (Staak Dep. at 13-17 Palacios Dep. at 13-17.) Plaintiff never worked in any of those departments. (Staak Dep. at 15-23, 50-51.)

Boehringer provided Plaintiff with a Physician Target Report, which was a list of 250 physicians in her territory that Boehringer identified as targets for visits by Plaintiff within a six-month period. (Palacios Dep. at 80:24-81:3.) Plaintiff was not allowed to forego calling on a particular target assigned by Boehringer, nor was she permitted to deviate, either upwards or downwards, from the number of visits specified in the target list. (Palacios Decl. ¶¶ 22-23, 32.) PSRs such as Plaintiff were subject to discipline and/or reprimanded if they failed to adhere to their assigned target lists. (Palacios Decl. ¶ 37.)

Plaintiff visited between eight and ten physicians a day. (Palacios Dep. at 104:14-17.) Each week, Plaintiff planned out which physicians she would visit and when. (Palacios Dep. at 112: 24-113:3.) In preparation for a meeting with a physician, Boehringer provided Plaintiff with a book that listed the drugs to be promoted and set forth “what the message was going to be for that drug ... all PSRs were to consistently use those words verbatim to the physician.” (Palacios Decl. ¶ 38.) Plaintiff was not permitted to alter this core message, and she was not permitted *1360 to speak to physicians about the off-label use of drugs, or compare Boehringer’s products with those of Boehringer’s competitors unless specifically instructed to do so by Boehringer’s headquarters. (Palacios Decl. ¶ 41.)

Boehringer provided Plaintiff with promotional materials to use during her meetings with physicians and trained her on how to use the materials. (Palacios Dep. at 121: 12-13, 161:1-6.) Plaintiff determined which promotional materials to use and how best to incorporate them into her presentation with each physician. (Staak Aff. ¶ 10.) Plaintiff used information she learned about a specific physician’s objection to certain medicines to effectively present information to that physician. (Palacios Dep. at 120: 17-121:7.) Boehringer also provided Plaintiff with samples of the products for which she was responsible, and she, in turn, gave the samples to the physicians she visited. (Staak Aff. ¶11.)

In a majority of her visits with physicians, Plaintiff asked if they would prescribe her products to patients where treatment with one of them was appropriate. (Palacios Dep. at 156: 25-157:9.) While the physicians might tell her if they were going to write a prescription for her products, the physicians’ commitments were non-binding, and neither Plaintiff nor Boehringer had a way of knowing whether a specific physician actually prescribed her products. (Palacios Dep. at 154:22-23.)

Plaintiff and her Geo Team received a budget of approximately $25,000-$30,000 per year to divide among themselves for providing food to physicians’ offices and hosting physicians outside their offices. (Palacios Dep. at 131:5-7.) Plaintiff had access to $8,333-$10,000 of that budget. (Palacios Dep. at 131:8-9.) Plaintiff had no input in determining the budget, nor could she deviate from the budget that Boehringer assigned to her. (Palacios Decl. ¶ 57.) However, Boehringer expected Plaintiff to allocate her budget based on her analysis of her territory. (Staak Aff. ¶ 13.) Plaintiff used her budget to purchase food and organize “lunch-and-learn” sessions with physicians in order to spend more time with them promoting Boehringer’s products. (Palacios Dep. at 125: 11-19; 170: 11-17.)

During her early years of employment (pre-2007), Plaintiff was also involved in organizing Speaker Programs with her Geo Team. (Palacios Dep. at 144: 6-9; Palacios Decl. ¶ 48.) Plaintiff selected speakers from Boehringer’s pre-approved list of physicians, and Boehringer negotiated a price for the speakers. (Staak Dep. at 27: 9-28:1.) Plaintiff used Speaker Programs to build relationships with physicians and to gain access to physicians who might otherwise not see her when she visited their offices. (Palacios Dep. at 144: 11-22.)

Plaintiff performed her job free of daily in-person supervision, with the exception of “ride alongs” every six weeks, during which her district manager would accompany her on her physician visits. (Palacios Dep. at 109: 8-12.) The district manager conducted the “ride alongs” to ensure that Plaintiff was not deviating from Boehringer’s core message when she met with physicians. (Palacios Dep. at 109: 8-12.) Plaintiff was responsible for tracking her daily activities using a computer system called VISTA. (Staak Dep. at 89:1-16; Conklin Dep. at 217: 12-23; Palacios Decl. ¶ 66.) Plaintiffs managers had access to the information she entered and could oversee her daily activities. (Staak Dep. at 89:1-16; Conklin Dep. at 217: 12-23; Palacios Decl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

KUZINSKI v. Schering Corp.
801 F. Supp. 2d 20 (D. Connecticut, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
814 F. Supp. 2d 1357, 2011 WL 2837464, Counsel Stack Legal Research, https://law.counselstack.com/opinion/palacios-v-boehringer-ingelheim-pharmaceuticals-inc-flsd-2011.